Prior authorization denials and the appeal path.
An authorization denial is not a financial loss the way a claim denial is — nothing has been billed yet, and the practice still has real options. The risk isn't the denial itself, it's what happens if the practice proceeds with care anyway before those options are worked.
Key takeaways
- An authorization denial is a decision point, not a loss. It happens before the service is delivered, while a claim denial happens after — and the cost is already sunk by then.
- The typical path runs reconsideration, peer-to-peer, then formal appeal, with an external review option beyond that in some states.
- Proceeding without authorization is what turns the decision point into a loss. Most contracts treat the missing authorization as the practice's failure, not the patient's.
- Urgent and emergent care changes the calculus — but only when the decision to proceed is deliberate and documented, not default.
Why an authorization denial isn't the same event as a claim denial
The two get treated interchangeably in a lot of practices, and that's a mistake, because they sit at opposite ends of the revenue cycle and carry entirely different financial stakes. An authorization denial happens before the service is delivered and before anything has been billed. Nothing has been lost yet — what exists is a decision that needs to be challenged or worked around, with real paths available: request a peer-to-peer, file a formal appeal, gather additional documentation for reconsideration, or reschedule the service while those paths run their course.
A claim denial is different in kind, not just in timing. By the time a claim denies, the service has already been delivered, the cost has already been incurred, and the practice is trying to recover money for care it can't take back. That's a fundamentally worse position to be negotiating from, because the leverage has shifted: instead of "please approve this before we proceed," the conversation becomes "please pay for something that's already happened," and payers are, unsurprisingly, more resistant to the second conversation than the first. Understanding this distinction is what should drive urgency on an authorization denial — not because the denial itself is catastrophic, but because doing nothing is what converts it into the far worse position of a claim denial.
The typical appeal path
Most payers run some version of the same basic structure after an initial authorization denial, though the exact steps, sequencing, and deadlines are payer- and plan-specific enough that the denial notice itself, not general knowledge, should be the source of truth for any specific case.
| Level | What it involves |
|---|---|
| Reconsideration | A first-level review, sometimes informal, often triggered by submitting additional documentation that wasn't part of the original request |
| Peer-to-peer review | A direct call between the treating physician and the payer's medical director — frequently the fastest route to reversal; see our dedicated peer-to-peer review guide |
| Formal written appeal | A structured submission with supporting clinical documentation, reviewed against the payer's internal appeals process and its own deadlines |
| External review | Available in some states as an independent review outside the payer, generally the last step if the internal appeal is unsuccessful |
The practical guidance that matters more than the structure itself is sequencing discipline: request the peer-to-peer immediately rather than waiting to see whether a formal appeal will be necessary, since the peer-to-peer window is typically the shortest deadline in the whole path and is the easiest one to accidentally forfeit by treating it as a lower priority than the written appeal. Working the levels roughly in order, and tracking the deadline for each one against the date the denial was actually received rather than the date someone got around to reading it, is what keeps a denial from stalling out at any single stage.
The real risk: proceeding without a favorable determination
The financial danger in this whole category isn't the denial — it's the decision to move forward with a scheduled service on the assumption that the authorization will come through eventually, or that it "should" apply once approved. Most payer contracts treat a missing or denied authorization as the practice's administrative failure rather than the patient's responsibility, which means the service delivered without a favorable determination is very often a full write-off with no path to bill the patient for it. That's what makes an authorization denial expensive: not the denial itself, but skipping the appeal path in favor of proceeding anyway.
This is also where the connection to the rest of the prior authorization workflow matters. A practice that tracks authorization status against its schedule, the way described in our authorization tracking guide, catches a stalled or denied request before the appointment happens, which preserves every option described above. A practice without that tracking often doesn't notice the authorization was never resolved until the appointment has already occurred, at which point the only paths left are the weaker post-service ones.
When it's acceptable to proceed anyway
There is one legitimate exception to working the appeal path before delivering care: urgent or emergent situations, where waiting for an authorization decision carries a real clinical risk to the patient that outweighs the financial risk of proceeding without one. Even here, the exception isn't a blanket rule that emergencies bypass authorization requirements entirely — most payers have separate, faster processes for genuinely urgent requests, and many services never required prior authorization to begin with in a true emergency. What changes is the calculus for the narrower set of cases where a service is authorization-dependent, the decision hasn't come back, and the clinical situation genuinely can't wait.
In those cases, the decision to proceed has to be made deliberately, by the practice and, where possible, discussed with the patient, and it has to be documented at the time — the clinical reasoning for why waiting wasn't an option, not just the fact that the service happened. That documentation is frequently what a later appeal, or an internal review of the resulting write-off, will actually turn on. For every case that isn't genuinely urgent, the appeal path is almost always the faster and cheaper option compared to the write-off risk of an unauthorized service, and treating "proceed anyway" as the default for anything short of true urgency is how avoidable losses accumulate.
Authorization denials piling up without a clear appeal process?
We work every denial through reconsideration, peer-to-peer, and formal appeal on a tracked timeline, so a decision point doesn't quietly become a write-off.
Frequently asked questions
Is an authorization denial the same as a claim denial?
No. An authorization denial happens before the service is delivered, so it's a decision point rather than a financial loss — nothing has been billed yet, and the practice still has options: reconsideration, peer-to-peer, a formal appeal, or rescheduling. A claim denial happens after the service was already delivered and billed, at which point the cost is sunk and the only question left is whether it's recoverable. Treating an authorization denial with the same urgency as a claim denial, rather than as a still-open decision, is what keeps it from becoming one.
What's the typical appeal path after an authorization denial?
Most payers run some version of reconsideration, then peer-to-peer review, then a formal written appeal, and in some states an external review beyond that if the internal appeal is unsuccessful. The exact sequence, deadlines, and what's required at each level are payer- and plan-specific, so treat this structure as a general map and confirm the specific steps against the denial notice and the payer's current policy.
When is it acceptable to proceed with care that hasn't been authorized?
Almost only in urgent or emergent situations, where the clinical risk of waiting for a decision outweighs the financial risk of proceeding without one — and that's a decision the practice and patient make deliberately and document at the time, not something that happens by default because a schedule was already set. For elective and non-urgent services, working the appeal path is almost always faster and cheaper than an unauthorized write-off, since most payer contracts treat a missing authorization as the practice's failure rather than the patient's responsibility.
Confirm before you rely on this. Prior authorization requirements, payer portals and turnaround times change by payer, plan and service. The process information on this page reflects standard industry practice as of August 2026 and is provided for general education — verify current requirements directly with the specific payer before relying on it.